Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Turan, Raife Dilek  [Clear All Filters]
2018
Aksoz M, Albayrak E, Aslan GServet, Turan RDilek, Alyazici LYazgi, Siyah P, Tusuz ECan, Canikyan S, Yucel D, Meric N, et al. c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression. Curr Cancer Drug Targets. 2018.
2020
Taştan C, Kancagi DDilek, Turan RDilek, Yurtsever B, Cakirsoy D, Abanuz S, Yilanci M, Seyis U, Ozer S, Mert S, et al. Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) targeting CD19-expressing B Cells for the First Turkish Academic Clinical Trial with Relapsed/refractory ALL and NHL Patients. Turk J Haematol. 2020.
2022
Albayrak E, Akgol S, Turan RDilek, Uslu M, Kocabas F. BML-260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability. J Cell Biochem. 2022.
2023
Sert B, Gulden G, Teymur T, Ay Y, Turan RDilek, Unaldi OMert, Guzenge E, Erdil HEmir, Isik S, Oz P, et al. Enhancing CAR-T cells: unleashing lasting impact potential with phytohemagglutinin activation in in vivo leukemia model. Cancer Gene Ther. 2023.
Hemsinlioglu C, Aslan ESibel, Taştan C, Cakirsoy D, Turan RDilek, Seyis U, Elek M, Karakuş GSir, Günaydın ÖSelin, Abanuz S, et al. In Vitro FVIII Encoding Transgenic Mesenchymal Stem Cells Maintain A Successful Coagulation in FVIII- Deficient Plasma Mimicking Hemophilia A. Turk J Haematol. 2023.